Agnosia, a condition characterized by the inability to recognize and process sensory information, is a significant symptom in Alzheimer's Disease (AD) and other forms of dementia. In AD, agnosia typically manifests as visual agnosia, where patients struggle to recognize familiar faces or objects, despite having intact vision. This impairment arises from damage to the brain's parietal and occipital lobes, regions crucial for integrating sensory input and forming coherent perceptions. As dementia progresses, the severity of agnosia can increase, compounding the challenges faced by patients in daily life. Understanding agnosia's role in AD underscores the broader cognitive decline, emphasizing the need for comprehensive care strategies that address both memory loss and perceptual deficits.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States